1. Analysis of the Effect of Increased α2,3-Sialylation on RTK Activation in MKN45 Gastric Cancer Spheroids Treated with Crizotinib
- Author
-
Meritxell Balmaña, Francisca Diniz, Tália Feijão, Celso A. Reis, Stefan Mereiter, Cristina C. Barrias, and Instituto de Investigação e Inovação em Saúde
- Subjects
Antineoplastic Agents / pharmacology ,Receptor Protein-Tyrosine Kinases / metabolism ,Tyrosine-kinase inhibitor ,Receptor tyrosine kinase ,RNA, Small Interfering / metabolism ,lcsh:Chemistry ,3D cell culture ,crizotinib ,gastric cancer ,glycosylation ,MET ,receptor tyrosine kinase ,RON ,sialylation ,spheroids ,tyrosine kinase inhibitor ,0302 clinical medicine ,Crizotinib / pharmacology ,Stomach Neoplasms / metabolism ,Medicine ,RNA, Small Interfering ,lcsh:QH301-705.5 ,Spectroscopy ,0303 health sciences ,biology ,General Medicine ,3. Good health ,Computer Science Applications ,Sialyltransferases / metabolism ,030220 oncology & carcinogenesis ,Tyrosine kinase ,medicine.drug ,medicine.drug_class ,Antineoplastic Agents ,Stomach Neoplasms / drug therapy ,Article ,Catalysis ,Inorganic Chemistry ,03 medical and health sciences ,Stomach Neoplasms ,Cell Line, Tumor ,Humans ,Physical and Theoretical Chemistry ,Protein Kinase Inhibitors ,Molecular Biology ,030304 developmental biology ,Crizotinib ,business.industry ,Protein Kinase Inhibitors / pharmacology ,Organic Chemistry ,Receptor Protein-Tyrosine Kinases ,Cancer ,medicine.disease ,Sialyltransferases ,Insulin receptor ,lcsh:Biology (General) ,lcsh:QD1-999 ,Tumor progression ,Cancer cell ,biology.protein ,Cancer research ,business - Abstract
In the scenario of personalized medicine, targeted therapies are currently the focus of cancer drug development. These drugs can block the growth and spread of tumor cells by interfering with key molecules involved in malignancy, such as receptor tyrosine kinases (RTKs). MET and Recepteur d’Origine Nantais (RON), which are RTKs frequently overactivated in gastric cancer, are glycoprotein receptors whose activation have been shown to be modulated by the cellular glycosylation. In this work, we address the role of sialylation in gastric cancer therapy using an innovative 3D high-throughput cell culture methodology that mimics better the in vivo tumor features. We evaluate the response to targeted treatment of glycoengineered gastric cancer cell models overexpressing the sialyltransferases ST3GAL4 or ST3GAL6 by subjecting 3D spheroids to the tyrosine kinase inhibitor crizotinib. We show here that 3D spheroids of ST3GAL4 or ST3GAL6 overexpressing MKN45 gastric cancer cells are less affected by the inhibitor. In addition, we disclose a potential compensatory pathway via activation of the Insulin Receptor upon crizotinib treatment. Our results suggest that cell sialylation, in addition of being involved in tumor progression, could play a critical role in the response to tyrosine kinase inhibitors in gastric cancer. This research was funded by the project NORTE-01-0145-FEDER-000029, supported by Norte Portugal Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). This work was also funded by FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE (POCI-01-0145-FEDER-016585 and POCI-01-0145-FEDER-007274); and National Funds through the Foundation for Science and Technology (FCT), under the projects: PTDC/BBB-EBI/0567/2014 and PTDC/BBB-ECT/2518/2014. We acknowledge the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 748880 awarded to MB. We thank FCT for the PhD fellowship awarded to FD (SFRH/BD/137896/2018), for the IF research position IF/00296/2015 to CCB and the CEECIND/02760/2017 to S.M. Acknowledgments: The authors would like to thank Rossana Correia (HEMS, i3S Scientific platform) for support on cells processing. The authors acknowledge the support of the ALM i3S Scientific Platform, member of the PPBI (PPBI-POCI-01-0145-FEDER-022122).
- Published
- 2020
- Full Text
- View/download PDF